Skip to main content
. 2018 May 29;99(1):182–190. doi: 10.4269/ajtmh.17-0543

Table 3.

Impact on daily life of participants according to probable chronic stage CHIK infection status

Characteristics Chronic stage CHIK status* Total (N = 509)
Remission (N = 309) Symptomatic (N = 200)
Resumption of daily activities n (%)
 Impossible 3 (1.5) 3 (0.6)
 Hard 14 (4.5) 108 (54.3) 122 (24.0)
 Without difficulty 294 (95.1) 88 (44.2) 382 (75.2)
 Not applicable 1 (0.3) 1 (0.2)
Resumption of school/work n (%)
 Impossible 2 (1.0) 2 (0.4)
 Hard 23 (7.4) 70 (35.2) 93 (18.3)
 Without difficulty 223 (72.2) 36 (18.1) 259 (51.0)
 Not applicable 63 (20.4) 91 (45.7) 154 (30.3)
Resumption of sports activities, n (%)
 Impossible 7 (3.5) 7 (1.4)
 Hard 21 (6.8) 70 (35.2) 92 (18.0)
 Without difficulty 228 (74.0) 25 (12.6) 253 (49.9)
 Not applicable 59 (19.2) 97 (48.7) 156 (30.8)
Restricted social activity due to CHIK (%) 5 (1.6) 107 (53.8) 112 (22.1)
QoL mobility, n (%)
 No problem in walking 300 (97.1) 138 (69.4) 439 (86.2)
 Some problem in walking 6 (1.9) 54 (27.1) 60 (11.8)
 Confined to bed 3 (1.0) 7 (3.5) 10 (2.0)
QoL self-care, n (%)
 No problem 304 (98.4) 161 (80.4) 465 (91.3)
 Some problem 2 (0.6) 26 (13.1) 28 (5.5)
 Inability 3 (1.0) 13 (6.5) 16 (3.2)
QoL daily activities, n (%)
 No problem 302 (98.1) 133 (66.8) 435 (85.8)
 Some problem 3 (1.0) 56 (28.1) 59 (11.6)
 Inability 3 (1.0) 10 (5.0) 13 (2.6)
QoL pain/discomfort, n (%)
 None 299 (96.8) 17 (8.5) 316 (62.2)
 Moderate 10 (3.2) 176 (88.4) 186 (36.6)
 Extreme 6 (3.0) 6 (1.2)
QoL anxiety/depression, n (%)
 None 300 (97.1) 99 (49.8) 399 (78.5)
 Moderate 9 (2.9) 96 (48.2) 105 (20.7)
 Extreme 4 (2.0) 4 (0.8)
QoL score, median (Q1–Q3) 90 (90–100) 71 (60–80) 83 (75–95)

November 2014 to February 2015, Martinique (N = 509). CHIK = chikungunya; QoL = quality of life; Q1 = first quartile; Q3 = third quartile.

*

Presence of different signs was evaluated 3 months or more after clinical diagnosis of probable CHIK infection by phone interviews. Persistence of signs allowed the categorization of participants into two groups: 1) remission group and 2) symptomatic group. Differences between the two groups were all statistically significant (P < 0.05).

Items from the French version of the standardized EQ-5D questionnaire, measuring health outcome in terms of impact on QoL. The QoL score ranges from 0 to 100, with a score of 0 denoting the worst state in terms of health outcome and a score of 100 denoting the best state [34–35].